In general, B-ALL is characterized by the expression of CD19 (nearly 100% of cases), CD79a, cytoplasmic CD22 (cCD22), terminal deoxynucleotidyl transferase (TdT), and HLA-DR and a dim expression of CD45 [23]. This evidence concerns the gene DNTT and precursor B-cell acute lymphoblastic leukemia.